Carroll Financial Associates’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$125K Buy
1,730
+1,550
+861% +$97.2K 0.01% 481
2021
Q3
$10K Sell
180
-1,370
-88% -$83.3K ﹤0.01% 1216
2021
Q2
$101K Sell
1,550
-110
-7% -$6.94K 0.01% 581
2021
Q1
$99K Sell
1,660
-80
-5% -$4.36K 0.01% 570
2020
Q4
$82K Buy
1,740
+210
+14% +$8.84K 0.01% 555
2020
Q3
$50K Sell
1,530
-1,750
-53% -$60.3K ﹤0.01% 653
2020
Q2
$106K Buy
3,280
+2,250
+218% +$61.4K 0.01% 456
2020
Q1
$24K Sell
1,030
-1,640
-61% -$47.2K ﹤0.01% 746
2019
Q4
$78K Buy
+2,670
New +$70.9K 0.01% 555
2019
Q2
Sell
-110
Closed -$1K 1644
2019
Q1
$1K Buy
+110
New +$1.83K ﹤0.01% 1309

Other funds holding LRCX

Carroll Financial Associates's LRCX Position: Q4 2021 in Review

Carroll Financial Associates increased its Lam Research (LRCX) stake by 861% in Q4 2021, buying an estimated $97.2K and bringing the position to 1,730 shares worth $125K. The position accounts for 0.01% of the portfolio, ranked #481.

Carroll Financial Associates first reported a position in LRCX in Q1 2019 and has held it in 10 quarters since. 1,461 funds tracked by Wall St. Rank hold LRCX as of Q4 2021.

  • Carroll Financial Associates held 1,730 shares of Lam Research worth $125K as of Q4 2021.
  • Carroll Financial Associates bought 1,550 Lam Research shares in Q4 2021, an estimated $97.2K.
  • Lam Research made up 0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #481 holding.
  • Carroll Financial Associates first reported a position in Lam Research in Q1 2019 and has held it in 10 quarters since.
  • 1,461 funds tracked by Wall St. Rank held Lam Research as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.